ElliottPVichinskyMD

Pediatric Hematology & Oncology • Oakland, CA

Medical Director, Hematology/Oncology Dept, Children's Hospital & Research Center Oakland

Join to view full profile

Dr. Vichinsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vichinsky's full profile

Already have an account?

Office
747 52nd St
Oakland, CA 94609
Phone+1 510-428-3651

Fax+1 510-450-5647

Education & Training

U Washington Affil Hosps1976 - 1979
University of WashingtonResidency, Pediatrics, 1974 - 1976
State University of New York Downstate Medical Center College of MedicineClass of 1974, MD, CUM LAUDE ALPHA OMEGA ALPHA

Certifications & Licensure

CA State Medical License 1979 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com
Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Penicillin Prophylaxis in Sickle Cell Disease (PROPS) Start of enrollment: 1983 Aug 01
Completed
Phase 3
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) Start of enrollment: 2000 Jul 01
Completed
Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease Start of enrollment: 1999 Jun 01
Completed
Not Applicable
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases Start of enrollment: 2005 Jun 01
Terminated
Phase 2
Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence Start of enrollment: 2005 Aug 01
Completed
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox Start of enrollment: 2007 May 01
Completed
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease Start of enrollment: 2004 Dec 01
Completed
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study Start of enrollment: 2004 Dec 01
Completed
Phase 1
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions Start of enrollment: 2009 Jul 01
Completed
Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload Start of enrollment: 2007 Sep 01
Completed
Phase 2
Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension Start of enrollment: 2009 Mar 01
Completed
Phase 2
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease Start of enrollment: 2009 Aug 01
Completed
Phase 2
Multi-Center Study of Iron Overload: Pilot Study Start of enrollment: 2009 Nov 01
Completed
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia Start of enrollment: 2010 May 01
Completed
Phase 3
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients Start of enrollment: 2010 Jan 01
Completed
Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease Start of enrollment: 2012 Feb 01
Completed
Phase 1, Phase 2
Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN) Start of enrollment: 2012 Dec 13
Completed
Phase 3
Multi-Center Study of Iron Overload: Survey Study (MCSIO) Start of enrollment: 2010 Mar 31
Completed
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias Start of enrollment: 2014 Apr 17
Terminated
Phase 4
Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) Start of enrollment: 2014 Jul 08
Completed
Phase 2
Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration Start of enrollment: 2014 Jun 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

653 citations
Sickle cell disease
Gregory J. Kato, Frédéric B. Piel, Clarice D. Reid, Marilyn H. Gaston, Kwaku Ohene-Frempong
Nature Reviews. Disease Primers. 2018-03-15
342 citations
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga, Russell E. Ware, Videlis Nduba
The New England Journal of Medicine. 2019-06-13
37 citations
Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major.
Robert J. Klaassen, Nick Barrowman, Manuela Merelles-Pulcini, Elliott Vichinsky, Nancy Sweeters
British Journal of Haematology. 2014-02-01

Journal Articles

Transfusion Practices and Complications in Thalassemia
Vinod V Balasa, Sanjay J Shah, Monica B Pagano, Geetha Puthenveetil, Jennifer Andrews, Ashutosh Lal, Trisha E Wong, Alan K Ikeda, Jong H Chung, Jennifer C Yu, Elliott ..., Transfusion
A Phase 3 Trial of L-glutamine in Sickle Cell Disease
Rita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine

Abstracts/Posters

Trends in Iron Overload over Past Two Decades: Results from the Natural History of Iron Burden Study with the SQUID BiosusceptometerClinically Relevant Abstract
Elliott Vichinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/2019
Mitapivat (AG-348), an Oral PK-R Activator, in Adults with Non-Transfusion Dependent Thalassemia: A Phase 2, Open-Label, Multicenter Study in Progress
Elliott P. Vichinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Correlation of Voxelotor Exposure with Hemoglobin Response and Measures of Hemolysis in Patients from the HOPE Study
Elliott Vichinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Development of a Severity Score System for Thalassemia Syndromes
Elliott P. Vichinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Pilot Adult Sickle Cell Hematology Clinic in CaliforniaÍs Inland Empire Improves Patient Outcome
Elliott P. Vichinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) Study
Elliott P. Vichinsky, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
Join now to see all

Lectures

Incidence of Vaso-Occlusive Crisis Does Not Increase with Achieving Higher Hemoglobin Levels on Voxelotor Treatment or after Discontinuation: Analyses of the HOPE Study
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Moving From Science Fiction to Clinical Reality: Gene Therapy for Beta-Hemoglobinopathies
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia Following Completion of the Northstar Hgb-204 Study
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science
60th American Society of Hematology Annual Meeting - 11/30/2018
Join now to see all

Other

Overview of the clinical manifestations of sickle cell disease
Vichinsky EP
http://www.uptodate.com/contents/overview-of-the-clinical-manifestations-of-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2012-11-16
Overview of the management of sickle cell disease
Vichinsky EP, Field JJ, DeBaun MR
http://www.uptodate.com/contents/overview-of-the-management-of-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2013-02-21
Diagnosis of sickle cell syndromes
Vichinsky EP, Mahoney DH
http://www.uptodate.com/contents/diagnosis-of-sickle-cell-syndromes
UpToDate, Wolters Kluwer Health - 2012-07-24
Variant sickle cell syndromes
Vichinsky EP
http://www.uptodate.com/contents/variant-sickle-cell-syndromes
UpToDate, Wolters Kluwer Health - 2012-03-07
Acute pain management in adults with sickle cell disease
Vichinsky EP, DeBaun MR
http://www.uptodate.com/contents/acute-pain-management-in-adults-with-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2012-05-01
Pregnancy in women with sickle cell disease
Vichinsky EP
http://www.uptodate.com/contents/pregnancy-in-women-with-sickle-cell-disease
UpToDate, Wolters Kluwer Health - 2012-12-13
Sickle cell trait
Vichinsky EP
http://www.uptodate.com/contents/sickle-cell-trait
UpToDate, Wolters Kluwer Health - 2013-03-26
Join now to see all

Press Mentions

Sickle Cell Math Is Brutally Simple, but Not Widely TaughtDecember 28th, 2021
CRISPR Gene-Editing Clinical Trial at UCSF Aims to Cure Deadly Blood DiseaseDecember 28th, 2021
Sickle Cell Gift Adds $2M to Oakland Hospital’s Growing ProgramDecember 16th, 2021
Join now to see all

Grant Support

Prevention Of Complications In ThalassemiaCenters For Disease Control And Prevention2007–2011
Modulation Of Iron Deposition In SCD And Other HemoglobinopathiesNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
Ninth Cooley'S Anemia SymposiumNational Heart, Lung, And Blood Institute2009
Thalassemia Clinical Research NetworkNational Heart, Lung, And Blood Institute2005–2009
Core--Patient ServiceNational Heart, Lung, And Blood Institute2005–2007
Core--Clinical Research 1National Heart, Lung, And Blood Institute2005–2007
Eighth Cooley'S Anemia SymposiumNational Heart, Lung, And Blood Institute2005
Neuropsych In SCDNational Center For Research Resources2005
Conrol Of Oxidant-Stress Induced Injury And Mitochrondrial Dysfunction By TRENational Center For Research Resources2005
Comparison Of Combination Therapy With Magnesium Pidoate And Hydroxyurea, VSNational Center For Research Resources2005
Natural History IronNational Center For Research Resources2004–2005
THAL OsteoNational Center For Research Resources2004
THALNational Center For Research Resources2004
Stop IINational Center For Research Resources2004
ParvovirusNational Center For Research Resources2004
Control Of Oxidant-Stress Induced Injury And Mitochrondrial Dysfunction By Tre...National Center For Research Resources2004
Comparison Of Combination Therapy With Magnesium Pidoate And Hydroxyurea, Vs....National Center For Research Resources2004
Secondary Hemochromatosis In Beta Thalassemia And SCDNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
California Thalassemia Clinical Research CenterNational Heart, Lung, And Blood Institute2000–2004
Randomized Trial For Core Decompression In Sickle Cell AnemiaNational Heart, Lung, And Blood Institute1998–2002
E/Beta Thalassemia--Natural History &Response To ChemoNational Heart, Lung, And Blood Institute1998–2002
Pathophysiology And Treatment In Sickle Cell Disease--Stroke Prevention TrialNational Center For Research Resources1998–2002
Pathophysiology And Treatment In Sickle Cell Disease--Pediatric HydroxyureaNational Center For Research Resources1998–2002
Cooperative Study Of Sickle Cell DiseaseNational Center For Research Resources1998–2002
Multicenter Study Of Hydroxyurea In Sickle Cell DiseaseNational Center For Research Resources2000
Avascular Necrosis Of The HIP In Sickle Cell DiseaseNational Center For Research Resources2000
Pediatric Cohort Of The CsscdDivision Of Blood Diseases And Resources1994–1998
Stroke Prevention Trial In Sickle Cell DiseaseNational Center For Research Resources1997
Pediatric HydroxyureaNational Center For Research Resources1997
Cooperative Study Of Sickle CellNational Center For Research Resources1997
Pathophysiology &Treatment Of Sickle Cell Anemia--Acute Chest StudyNational Center For Research Resources1996–1997
Pathophysiology &Treatment Of Sickle Cell Anemia--Stroke Prevention TrialNational Center For Research Resources1996
Pathophysiology &Treatment Of Sickle Cell Anemia--Pediatric HydroxyureaNational Center For Research Resources1996